09887.HK
Nanjing Leads Biolabs Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 36.00
−2.65%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +349.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -35.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026